NCT01435252View on ClinicalTrials.gov

A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab

PHASE2CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

September 19, 2011

Primary Completion Date

October 25, 2017

Study Completion Date

October 25, 2017

Conditions
Oropharyngeal CancerHypopharyngeal CancerLaryngeal Cancer
Interventions
DRUG

Cetuximab

Arm A: chemoradiation in combination with concurrent cetuximab Arm B: chemoradiation in combination with concurrent and consolidation cetuximab

Trial Locations (1)

Unknown

University Hospital, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT01435252 - A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab | Biotech Hunter | Biotech Hunter